Please login to read the full article.
Scrip Regulatory Affairs
EU medtech report calls for randomised clinical trials and centralised pre-market evaluation
06 July 2011
Amanda Maxwell
Please login to read the full article.
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- FDA report questions whether US rules can ensure quality of marketed medical devices
- UK PIP report largely vindicates EU medtech system but highlights need for improvements
- EMA's ATMP classification proposals out for consultation
- EU Council proposes ways to improve medical device regulations and facilitate path for innovation
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
